ACTRN12619001686190
已完成
未知
The impact of lung function testing (spirometry) on clinical decision making and quality of life in children, a single centre randomised controlled trial (RCT).
Dr Wicharn Boonjindasup0 个研究点目标入组 106 人2019年12月2日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Respiratory disorders
- 发起方
- Dr Wicharn Boonjindasup
- 入组人数
- 106
- 状态
- 已完成
- 最后更新
- 3年前
概览
简要总结
- Research question Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in pulmonology clinics? 2. Background information Spirometry is recommended as an adjunct test in many respiratory practice guidelines. However, there is a paucity of high-quality evidence to support the routine use of spirometry in children. 3. Participant characteristics Children able to perform reliable spirometry with parent/guardian in attendance 4. Key results Using spirometry with clinical review significantly altered doctors’ clinical decisions, especially in follow-up schedule and patient education; and improved patient-reported outcome measures. 5. Limitations This is a non-blinded study. The study was undertaken in a specialist children hospital, so data may not be applicable in other settings. In addition, findings are limited to a single timepoint assessment, and could not determine long term outcomes.
研究者
入排标准
入选标准
- •A child with parents/guardians in attendance and able to provide written consent.
- •A child aged from 4 to 18 years, who can perform acceptable spirometry
- •Parent/guardian that is able to complete QoL questionnaires
- •A child whose physician is willing to being part of the LoCQ Study
排除标准
- •Previously enrolled
- •Contraindication for spirometry including dyspnoea, pneumothorax, haemoptysis, vital signs instability, lung cyst or bleb, and recent chest/eye surgery (\<3 weeks)
结局指标
主要结局
未指定
相似试验
招募中
不适用
Pulmonary Function Assessment and Evaluation Using Self-administrable and Portable Electrical Impedance TomographyLung DiseasesNCT05346081Queen Mary Hospital, Hong Kong125
已完成
3 期
The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPDPulmonary Disease, Chronic ObstructiveNCT01777334GlaxoSmithKline905
已完成
不适用
Perioperative Lung Function Monitoring After Anatomic Lung ResectionsLung Function DecreasedLung DiseasesSurgeryNCT03054675Insel Gruppe AG, University Hospital Bern328
进行中（未招募）
不适用
The association between various diagnostic measurements and lung functioISRCTN45778591niversity Hospital of Basel20,000
招募中
不适用
Breath analysis of the patients with few missing teeth after the placement of removable artificial teeth setHealth Condition 1: K084- Partial loss of teethCTRI/2024/07/071718Dr.Prudhvi Rudraraju